Objective: To compare the efficacy and safety of intravenous amiodarone and propafenone for broad QRS tachycardia. 目的:观察和比较静脉注射胺碘酮、普罗帕酮治疗宽QRS波群心动过速的即时疗效和安全性。
Other drugs such as flecainide and propafenone can help maintain a normal rhythm. 其他药物,如氟卡尼和普罗帕酮可以帮助维护正常的节奏。
Objective To compare the efficacy and side effects of propafenone and metoprolol therapies on ventricular or supraventricular extrasystole induced by viral myocarditis ( VM). 目的比较普罗帕酮和美托洛尔治疗病毒性心肌炎(VM)所致室上性和室性期前收缩的疗效和不良反应。
Methods In this paper, using propafenone and verapamil to treat paroxysmal supraventricular tachycardia patients, and comparing their clinical efficacy. 方法本文分别采用普罗帕酮和维拉帕米治疗PSVT患者,并对两个药物进行疗效对比。
Objective To study the stability of injection of propafenone hydrochloride. Preparation and characteristics of propafenone hydrochloride inclusion complex 目的考察盐酸普罗帕酮注射液的稳定性。盐酸普罗帕酮包合物的制备及其性质研究
Systematic review of comparative study on the efficacy of amiodarone versus propafenone for the conversion of atrial fibrillation 胺碘酮与普罗帕酮转复心房颤动疗效对比研究的系统评价
Effect of propafenone on pacing threshold in dogs 普罗帕酮对犬的起搏阈值影响的实验研究
Propafenone; Left ventricular outflow tract; Electrophysiology. 普罗帕酮;左心室流出道;电生理。
Influence of propafenone on anoxic cardiac arrest and hypoxia tolerance 普罗帕酮对缺氧性心脏停搏缺氧耐受作用的研究
Clinic Analysis on 120 Cases of Propafenone on Paroxysmal Supraventricular Tachycardia 普罗帕酮急诊转复阵发性室上性心动过速120例临床分析
Clinical Observation of Propafenone in Treating Paroxysmal Supraventricular Tachycardia 普罗帕酮治疗阵发性室上性心动过速的疗效观察
Conclusion Establishing animal model of acute heart failure in rat by using propafenone is a handy and credible method. 结论采用普鲁帕酮注射液复制大鼠急性心阳虚衰动物模型是一种简便可靠的方法。
Preparation of propafenone HCl inclusion complex sustained-release tablets and determination of its drug release 盐酸普罗帕酮包合物缓释片的制备及体外释放度的研究
Objective: It is to observe the effect of propafenone and amiodaron on chronic heart failure complicated with premature ventricular beats. 目的:观察心律平、可达龙治疗慢性心衰合并室早的疗效。
Results After treatment, propafenone group, the better Isoptin group, and the low rate of adverse reactions. 结果经过治疗后,心律平组的疗效优于异搏定组,且不良反应率低。
Objective To compare the long term efficacy and safety of propafenone with moricizine in patients with paroxysmal atrial fibrillation. 目的比较普罗帕酮和莫雷西嗪对阵发性心房颤动(房颤)患者进行较长期预防发作的疗效和安全性。
Conclusion: Propafenone is safe to treat rapid arrhythmia in the patients of Kawasaki disease. 结论:普罗帕酮是一个治疗小儿川崎病心律失常的安全有效的药物,但对于合并有冠状动脉病变的患儿疗效稍差。
The mediums for dissolution test were selected to improve the dissolution rate of propafenone hydrochloride tablets. 本文通过筛选6种溶出介质,以提高难溶性药物盐酸普罗帕酮片的溶出度,建立该药品溶出度测定方法。
Conclusion It's better to use propafenone hydrochloride with the photophobic syringe in 8 h in ICU. 结论盐酸普罗帕酮注射液在避光注射器中较稳定,建议ICU使用避光注射器,并在8h内用完。
Steady-state peak and trough concentrations of propafenone were measured by HPLC method. 普罗帕酮稳态峰、谷浓度采用高效液相色谱分析法测定。
CONCLUSION the microcapsule propafenone has the stable slow-released drug effect and reaches the standards of long-acting treatment for anti-arrhythmia. 结论普罗帕酮微囊具有显著平稳缓释药物作用,达到抗心律失常缓释长效的治疗目的。
A study of pharmacokinetics on propafenone taken orally in normal subjects and cardiac patients 正常人与病人口服心律平的药代动力学研究
Conclusion Propafenone and amiodarone reduce cardiac sensing function of patients with pacemaker. 胺碘酮也可降低IDA及SR,但与血药浓度无关。结论普罗帕酮和胺碘酮均可降低安置起搏器病人的心脏感知功能。
METHODS After iv administration of propafenone and quinidine, the drug levels in plasma were measured by HPLC. 方法采用高效液色谱法测定家兔给药后不同时间的普罗帕酮和奎尼丁的血药浓度。
AIM: To investigate the stereoselective metabolism of propafenone ( PPF) by human liver CYP3A4. 目的:研究普罗帕酮(PPF)经人肝CYP3A4代谢的立体选择性。
Objective: To verify the feasibility of bacterial endotoxins test in detecting propafenone hydrochloride injection. 目的:验证盐酸普罗帕酮注射液细菌内毒素检查法的可行性。
Objective To investigate influence of propafenone and amiodarone on sensing function of pacemaker, namely cardiac sensing parameter. 目的探讨抗心律失常药物-普罗帕酮和胺碘酮对心脏感知功能,即感知参数的影响。
Objective: To study the electrophysiology effect of Propafenone on ventricle muscle cell of rats. 目的:研究普罗帕酮对心室肌细胞的影响作用。
ObjectiveTo compare the efficacy and safety of intravenous amiodarone versus propafenone for immediate cardioversion of re cent-onset atrial fibrillation. 目的比较胺碘酮与普罗帕酮静脉给药转复新近发生心房颤动的有效性和安全性。